[Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D014667:Vasopressins / Q000031:analogs & derivatives*
D014667:Vasopressins; D003894:Deamino Arginine Vasopressin
Essai clinique d'un nouvel analogue synthétique de la vasopressine le DDAVP (1-deamino-8-D-arginine-vasopressine) dans le traitement du diabète insipide de l'enfant